It facilitates the translation of IGF1R, activating the PI3K-AKT/S6 signaling pathway to confer radioresistance, thereby emerging as a promising therapeutic target for NPC radiosensitization. This evidence concerns the gene AKT1 and nasopharyngeal carcinoma.